Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > More Than $7 With Combined Indications

<< Previous

Bullboard Posts

Next >>

Comment by 2b7f6fabon Sep 14, 2024 2:26pm

245 Views

Post# 36223936

RE:More Than $7 With Combined Indications

All good points Bigkahuna57. We should be getting close to BTD. I don't remember if it was a conversation I had with the IR guy or in a press release but TLT now has central pathology lab data on 25 patients. Which should be sufficient to apply for BTD. Here's hoping.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments